JSM 2015 Preliminary Program

Online Program Home
My Program

Legend: Washington State Convention Center = CC, Sheraton Seattle = S, Grand Hyatt = GH and The Conference Center = TCC
* = applied session       ! = JSM meeting theme

Activity Details
345 * Tue, 8/11/2015, 10:30 AM - 12:20 PM CC-619
Some Challenges and Advances in Heterogeneous Treatment Effect Evaluation and Trial Design Considerations — Topic Contributed Papers
Biopharmaceutical Section , Biometrics Section
Organizer(s): Mike Shi, Takeda Pharmaceuticals
Chair(s): Guoliang 'Charlie' Cao, Takeda Pharmaceuticals
10:35 AM Repeated Measures vs. Crossover: Selecting an Optimal Design for a Pivotal Trial — Theodore Lystig, Medtronic, Inc.
10:55 AM Detecting Outlying Trials in Network Meta-Analysis — Jing Zhang, University of Maryland ; Haoda Fu, Eli Lilly and Company ; Bradley P. Carlin, University of Minnesota
11:15 AM Challenges of Psychiatric Clinical Trials: Methods to Mitigate Placebo Responses — Mike Shi, Takeda Pharmaceuticals ; Wei Zhong, Takeda Pharmaceuticals
11:35 AM Systemic Utilization of Phase II Interim Efficacy Analysis to Expedite Drug Development — Jie Huang, Genentech, Inc./Roche
11:55 AM Assessing Consistency of Treatment Effect in Multiregional Clinical Trials — Bin Zhang, Millennium Pharmaceutical, Inc. ; Zhaoyang Teng, Takeda Pharmaceutical International Co. ; Jing Wang, Gilead Sciences
12:15 PM Floor Discussion




For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home